<DOC>
	<DOCNO>NCT01775878</DOCNO>
	<brief_summary>The study two-arm , parallel-comparison , single-blind , randomize control trial , offer Kaiser Permanente member age 18 - 75 year old present Santa Rosa Diabetes Care Management Center Type 2 diabetes mellitus . Participants randomly assign one two treatment arm . The telemedicine group group receive usual care ( control group ) . This study hop show usefulness telemonitoring technology specifically , ass whether device improve marker control diabetes , glycemic control , cardiovascular risk factor</brief_summary>
	<brief_title>Diabetes Care Management Trial Telemetric Monitoring</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>18 75 year old , diagnosis type 2 diabetes mellitus least 1 month , eligible refer diabetes care management program , HbA1c value range : 7.5 % 10.5 % . Weight &gt; 330 lb , estimate glomerular filtration rate ( GFR ) &lt; 45 , unstable coronary artery disease , severe peripheral vascular disease restrict exercise , endstage liver disease , undergoing treatment cancer , pregnant use appropriate birth control , broadband internet access home .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>HbA1c</keyword>
	<keyword>Fructosamine</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>Telemonitoring</keyword>
</DOC>